{"product_id":"mer-primary-care-conferences-internal-medicine-for-primary-care-cardio-endo-id-rheum-mar-30-apr-02-2026","title":"MER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo ID Rheum Mar 30 – Apr 02, 2026","description":"\u003ch1\u003eMER Primary Care Conferences Internal Medicine for Primary Care Cardio Endo ID Rheum Mar 30 – Apr 02, 2026\u003c\/h1\u003e\r\n\u003ch1\u003eInternal Medicine for Primary Care 2026 – Cardiology, Endocrinology, Infectious Diseases \u0026amp; Rheumatology\u003c\/h1\u003e\r\n\u003ch2\u003eFull Course Description\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eInternal Medicine for Primary Care 2026 – Cardiology, Endocrinology, Infectious Diseases \u0026amp; Rheumatology\u003c\/strong\u003e is a focused educational program designed to help clinicians strengthen everyday diagnostic and treatment decisions across four essential areas of adult medicine.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe program provides clinically relevant updates for office-based physicians and healthcare professionals managing common and complex conditions in primary care. It combines practical diagnostic frameworks, current guideline-based treatment strategies, risk assessment, differential diagnosis, and patient-specific management planning.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe course covers high-value topics in cardiovascular medicine, diabetes and endocrine disorders, musculoskeletal and inflammatory diseases, and common infectious diseases seen in outpatient practice.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants will review approaches to coronary artery disease risk assessment, hypertension management, heart failure treatment, arrhythmias, atrial fibrillation, dyslipidemia, and individualized cardiovascular care. Endocrinology sessions address type 2 diabetes, thyroid dysfunction, osteoporosis, bisphosphonate therapy, and lipid disorders.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eRheumatology content focuses on inflammatory arthritis, osteoarthritis, gout, pseudogout, fibromyalgia, and practical differential diagnosis based on clinical findings and laboratory workup. Infectious disease topics include skin and soft tissue infections, respiratory infections, diarrheal illness, emerging infections, zoonotic disease, and vaccine-preventable disease resurgence.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis course is ideal for clinicians who want a structured, practical review of evidence-based internal medicine for daily primary care practice.\u003c\/p\u003e\r\n\r\n\u003ch2\u003eOriginal Conference Dates\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003eMarch 30, 2026 – April 2, 2026\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eAfter completing this program, learners should be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDevelop individualized treatment plans for patients with type 2 diabetes.\u003c\/li\u003e\r\n \t\u003cli\u003eInterpret dyslipidemia diagnostic criteria and choose patient-specific treatment strategies.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess the benefits and risks of bisphosphonate therapy in osteoporosis.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize and evaluate abnormal thyroid function.\u003c\/li\u003e\r\n \t\u003cli\u003eDifferentiate inflammatory arthritis using clinical presentation and laboratory findings.\u003c\/li\u003e\r\n \t\u003cli\u003eApply current evidence to the management of osteoarthritis.\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnose and treat gout and pseudogout.\u003c\/li\u003e\r\n \t\u003cli\u003eCompare pharmacologic options for fibromyalgia, including benefits and adverse effects.\u003c\/li\u003e\r\n \t\u003cli\u003eReview the microbiology and management of skin and soft tissue infections.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify common pathogens causing respiratory tract infections.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate diarrhea severity and determine when treatment is necessary.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize emerging infectious diseases, zoonoses, and vaccine-preventable disease resurgence.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate patients with suspected coronary artery disease using appropriate work-up and risk assessment.\u003c\/li\u003e\r\n \t\u003cli\u003eApply current concepts in hypertension diagnosis and treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eUse evidence-based strategies for heart failure management.\u003c\/li\u003e\r\n \t\u003cli\u003eReview diagnostic and treatment approaches for arrhythmias and atrial fibrillation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWho Should Study This Course?\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis program is suitable for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eInternists\u003c\/li\u003e\r\n \t\u003cli\u003ePrimary care physicians\u003c\/li\u003e\r\n \t\u003cli\u003eFamily medicine physicians\u003c\/li\u003e\r\n \t\u003cli\u003eGeneral practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eCardiologists\u003c\/li\u003e\r\n \t\u003cli\u003eEndocrinologists\u003c\/li\u003e\r\n \t\u003cli\u003eRheumatologists\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious disease physicians\u003c\/li\u003e\r\n \t\u003cli\u003ePhysician assistants\u003c\/li\u003e\r\n \t\u003cli\u003eNurse practitioners\u003c\/li\u003e\r\n \t\u003cli\u003eOther office-based healthcare professionals\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eMain Topics Included\u003c\/h2\u003e\r\n\u003ch3\u003eCardiology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCoronary artery disease evaluation and risk assessment\u003c\/li\u003e\r\n \t\u003cli\u003eHypertension diagnosis and treatment\u003c\/li\u003e\r\n \t\u003cli\u003eHeart failure management\u003c\/li\u003e\r\n \t\u003cli\u003eArrhythmias and atrial fibrillation\u003c\/li\u003e\r\n \t\u003cli\u003eDyslipidemia diagnosis and individualized treatment\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-based cardiovascular risk reduction\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eEndocrinology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eType 2 diabetes treatment planning\u003c\/li\u003e\r\n \t\u003cli\u003eDyslipidemia and lipid management\u003c\/li\u003e\r\n \t\u003cli\u003eOsteoporosis treatment\u003c\/li\u003e\r\n \t\u003cli\u003eBisphosphonate benefits and risks\u003c\/li\u003e\r\n \t\u003cli\u003eThyroid function abnormalities\u003c\/li\u003e\r\n \t\u003cli\u003ePractical endocrine management in primary care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eRheumatology\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDifferential diagnosis of inflammatory arthritis\u003c\/li\u003e\r\n \t\u003cli\u003eOsteoarthritis treatment strategies\u003c\/li\u003e\r\n \t\u003cli\u003eGout and pseudogout\u003c\/li\u003e\r\n \t\u003cli\u003eFibromyalgia pharmacologic management\u003c\/li\u003e\r\n \t\u003cli\u003eClinical and laboratory evaluation of rheumatologic symptoms\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eInfectious Diseases\u003c\/h3\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSkin and soft tissue infections\u003c\/li\u003e\r\n \t\u003cli\u003eRespiratory tract infections\u003c\/li\u003e\r\n \t\u003cli\u003eCommon bacterial and viral pathogens\u003c\/li\u003e\r\n \t\u003cli\u003eDiarrheal illness assessment and treatment\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging infectious diseases\u003c\/li\u003e\r\n \t\u003cli\u003eZoonotic infections and animal exposure risks\u003c\/li\u003e\r\n \t\u003cli\u003eResurgence of vaccine-preventable diseases\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Valuable\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis program is especially useful for clinicians who manage a wide range of adult medical conditions in outpatient and primary care settings. It focuses on practical decision-making, common diagnostic challenges, current evidence, and treatment strategies that can be applied directly in daily practice.\u003c\/p\u003e\r\nThe content supports a patient-centered approach to chronic disease management, acute outpatient conditions, cardiovascular risk reduction, musculoskeletal complaints, endocrine disorders, and infectious disease assessment.\r\n\u003ch3 data-path-to-node=\"7\"\u003e4. Topics\u003c\/h3\u003e\r\n\u003cp data-path-to-node=\"8\"\u003e\u003cb data-path-to-node=\"8\" data-index-in-node=\"0\"\u003eEndocrinology\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"9\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-369\" data-path-to-node=\"9,0,1\"\u003e\u003cspan data-path-to-node=\"9,0,1,0\"\u003e\u003cb data-path-to-node=\"9,0,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-804\"\u003eType 2 Diabetes Mellitus\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-804\"\u003e: Diagnosis and treatment; lessons from the DCCT; managing diabetic emergencies; screening; pre-diabetes\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"9,0,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-370\" data-path-to-node=\"9,1,0\"\u003e\u003cspan data-path-to-node=\"9,1,0,0\"\u003e\u003cb data-path-to-node=\"9,1,0,0\" data-index-in-node=\"0\"\u003eLipid Metabolism and Treatment\u003c\/b\u003e: Review of the most recent American Heart Association Dietary and Lipid Guidelines; Discussion of the most recent ADA guidelines for lipid management for both primary and secondary CV prevention; \u003c\/span\u003e\u003cspan data-path-to-node=\"9,1,0,2\"\u003e\u003cspan class=\"citation-803\"\u003eDetail of treatments for elevated triglycerides and the lack of cardiovascular benefit from fish oil\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"9,1,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-371\" data-path-to-node=\"9,2,1\"\u003e\u003cspan data-path-to-node=\"9,2,1,0\"\u003e\u003cb data-path-to-node=\"9,2,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-800\"\u003eOsteoporosis\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-800\"\u003e: Review the epidemiology and pathophysiology of osteoporosis along with interp\u003c\/span\u003e\u003cspan class=\"citation-800 citation-801 citation-802 citation-end-802\"\u003eretation of DEXA scans and FRAX risk assessment; up-to-date therapeutic options\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"9,2,1,2\"\u003e\u003cspan class=\"citation-798 citation-799 citation-end-799\"\u003e.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-372\" data-path-to-node=\"9,3,1\"\u003e\u003cspan data-path-to-node=\"9,3,1,0\"\u003e\u003cb data-path-to-node=\"9,3,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-795 citation-796 citation-797\"\u003eDisorders of Thyroid Function\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-795 citation-796 citation-797 citation-end-797\"\u003e: Prevalence, diagnosis and treatment options of hypothyroidis\u003c\/span\u003e\u003cspan class=\"citation-795 citation-796 citation-end-796\"\u003em and hyperthyroidism\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"9,3,1,2\"\u003e\u003cspan class=\"citation-794 citation-end-794\"\u003e.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-373\" data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-793 citation-end-793\"\u003eRheumatology\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"11\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-374\" data-path-to-node=\"11,0,0\"\u003e\u003cspan data-path-to-node=\"11,0,0,0\"\u003e\u003cb data-path-to-node=\"11,0,0,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-792\"\u003eDifferential Diagnosis of Inflammatory Arthritis\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-792 citation-end-792\"\u003e: Cl\u003c\/span\u003einical presentation and laboratory work-up and treatment for rheumatoid arthritis, systemic lupus erythematosus, spondyloarthropathies (SPA), infectious arthritis and systemic sclerosis; Treatment of RA with DMARDs; \u003c\/span\u003e\u003cspan data-path-to-node=\"11,0,0,2\"\u003e\u003cspan class=\"citation-791\"\u003eTreatment principles of SLE, Sjogren’s, SPA and PMR\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"11,0,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-375\" data-path-to-node=\"11,1,1\"\u003e\u003cspan data-path-to-node=\"11,1,1,0\"\u003e\u003cb data-path-to-node=\"11,1,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-790\"\u003eOsteoarthritis\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-790\"\u003e: Pathogenesis, diagnosis and treatment\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"11,1,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-376\" data-path-to-node=\"11,2,1\"\u003e\u003cspan data-path-to-node=\"11,2,1,0\"\u003e\u003cb data-path-to-node=\"11,2,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-789\"\u003eCrystal Disease: Gout \u0026amp; Pseudogout\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-789\"\u003e: Properly diagnosing and treating crystal diseases such as gout and pseudogout\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"11,2,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-377\" data-path-to-node=\"11,3,0\"\u003e\u003cspan data-path-to-node=\"11,3,0,0\"\u003e\u003cb data-path-to-node=\"11,3,0,0\" data-index-in-node=\"0\"\u003eFibromyalgia\u003c\/b\u003e: Differential diagnosis and treatment of this difficult-to-manage pain syndrome; \u003c\/span\u003e\u003cspan data-path-to-node=\"11,3,0,2\"\u003e\u003cspan class=\"citation-788\"\u003eTreatment options of anti-epileptics and SNRI’s\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"11,3,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"12\"\u003e\u003cb data-path-to-node=\"12\" data-index-in-node=\"0\"\u003eInfectious Diseases\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"13\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-378\" data-path-to-node=\"13,0,1\"\u003e\u003cspan data-path-to-node=\"13,0,1,0\"\u003e\u003cb data-path-to-node=\"13,0,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-787\"\u003eSkin \u0026amp; Soft Tissue Infections\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-787\"\u003e: Presentation on important skin and soft-tissue infections and their prompt recognition, emphasizing evaluation and management strategies\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"13,0,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-379\" data-path-to-node=\"13,1,1\"\u003e\u003cspan data-path-to-node=\"13,1,1,0\"\u003e\u003cb data-path-to-node=\"13,1,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-786\"\u003eRespiratory Tract Infections\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-786\"\u003e: Discussion highlighting critical points regarding the diagnosis and management of pneumonia and bronchitis – with a focus on the impact of multidrug resistant pathogens\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"13,1,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-380\" data-path-to-node=\"13,2,1\"\u003e\u003cspan data-path-to-node=\"13,2,1,0\"\u003e\u003cb data-path-to-node=\"13,2,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-785\"\u003eGastrointestinal Infections \u0026amp; Clostridiodes Difficile\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-785\"\u003e: Presentation on important enteric pathogens and their recognition, diagnosis and management; special emphasis on clostridiodes difficile colitis and related updates from the ID and infection control literature\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"13,2,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-381\" data-path-to-node=\"13,3,1\"\u003e\u003cspan data-path-to-node=\"13,3,1,0\"\u003e\u003cb data-path-to-node=\"13,3,1,0\" data-index-in-node=\"0\"\u003e\u003cspan class=\"citation-784\"\u003eEmerging Infectious Diseases\u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"citation-784\"\u003e: Novel influenza viruses, resurgence of vaccine-preventable diseases, zoonoses and disease related to animal exposures (including vectors such as mosquitoes that bear west Nile virus and dengue), bioterrorism and food\/waterborne illness\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"13,3,1,2\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-path-to-node=\"14\"\u003e\u003cb data-path-to-node=\"14\" data-index-in-node=\"0\"\u003eCardiology\u003c\/b\u003e\u003c\/p\u003e\r\n\r\n\u003cul data-path-to-node=\"15\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-382\" data-path-to-node=\"15,0,0\"\u003e\u003cspan data-path-to-node=\"15,0,0,0\"\u003e\u003cb data-path-to-node=\"15,0,0,0\" data-index-in-node=\"0\"\u003eWork-up of Patients with Suspected CAD\u003c\/b\u003e: Risk factor evaluation and risk assessment models; Test selection including ECG, echo, nuclear and newer imaging modalities (including discussion of appropriate use criteria–AUC); The usefulness of CT scanning; The role of bio markers and EBCT; \u003c\/span\u003e\u003cspan data-path-to-node=\"15,0,0,2\"\u003e\u003cspan class=\"citation-783\"\u003eSuspected CAD in special populations (women, diabetics, the elderly)\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"15,0,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-383\" data-path-to-node=\"15,1,0\"\u003e\u003cspan data-path-to-node=\"15,1,0,0\"\u003e\u003cb data-path-to-node=\"15,1,0,0\" data-index-in-node=\"0\"\u003eHypertension\u003c\/b\u003e: The 2017 AHA\/ACC Hypertension Guidelines; The 2024 ESC Guidelines for hypertension; Approaches to treatment thresholds and goals; Choices for initial and combination therapy; Resistant hypertension; \u003c\/span\u003e\u003cspan data-path-to-node=\"15,1,0,2\"\u003e\u003cspan class=\"citation-782\"\u003eTreating special populations: diabetics, the elderly, patients with renal failure\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"15,1,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-384\" data-path-to-node=\"15,2,0\"\u003e\u003cspan data-path-to-node=\"15,2,0,0\"\u003e\u003cb data-path-to-node=\"15,2,0,0\" data-index-in-node=\"0\"\u003eHeart Failure\u003c\/b\u003e: Etiologies and stages of heart failure; ACC\/AHA Heart Failure Guidelines; Heart failure with reduced EF (HFrEF) and heart failure with preserved EF (HFpEF); Determining patients for referral using biomarkers, eg NT Pro BNP; Treatment options: ACE inhibitors, ARBs, ARNI, beta blockers, mineralocorticoid receptor antagonists, SGLT2i; The role of devices in treatment and antiplatelet drugs; \u003c\/span\u003e\u003cspan data-path-to-node=\"15,2,0,2\"\u003e\u003cspan class=\"citation-781\"\u003eIssues related to the hospitalized patient with acute decompensated heart failure and readmissions\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"15,2,0,4\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp id=\"p-rc_a78dbc88b71a7ec4-385\" data-path-to-node=\"15,3,0\"\u003e\u003cspan data-path-to-node=\"15,3,0,0\"\u003e\u003cb data-path-to-node=\"15,3,0,0\" data-index-in-node=\"0\"\u003eArrhythmias\u003c\/b\u003e: Types and symptoms of arrhythmias; Approach to the patient: when to treat, when to refer, when to admit; Evaluation of the patient with palpitations; Atrial fibrilation: the use of anticoagulants indications, CVA risk scores, warfarin vs newer oral anticoagulants, controlling heart rate vs rhythm; \u003c\/span\u003e\u003cspan data-path-to-node=\"15,3,0,2\"\u003e\u003cspan class=\"citation-778\"\u003eVentricular and other arrhythm\u003c\/span\u003e\u003cspan class=\"citation-778 citation-779 citation-780 citation-end-780\"\u003eias: when are they serious\u003c\/span\u003e\u003c\/span\u003e\u003cspan data-path-to-node=\"15,3,0,4\"\u003e\u003cspan class=\"citation-776 citation-777 citation-end-777\"\u003e.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43113247211618,"sku":"MED-AMB09516","price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/MER-Primary-Care-Conferences-Internal-Medicine-for-Primary-Care-Cardio-Endo-ID-Rheum-Mar-30-_E2_80_93-Apr-02-2026-2.jpg?v=1783964418","url":"https:\/\/meducourse.com\/products\/mer-primary-care-conferences-internal-medicine-for-primary-care-cardio-endo-id-rheum-mar-30-apr-02-2026","provider":"Meducourse","version":"1.0","type":"link"}